Ugolini V, Norcross J F, Schreiber J T, Kuntz R E, Taylor A L
J Am Coll Cardiol. 1986 May;7(5):1174-6. doi: 10.1016/s0735-1097(86)80241-8.
Peritoneovenous shunts have become an accepted mode of therapy for ascites refractory to medical treatment. However, their use is known to be associated with significant morbidity and mortality. Reported is the case of a patient with a Denver shunt who developed massive intracardiac thrombosis and subsequent shunt malfunction, despite preserved shunt patency.
腹腔静脉分流术已成为治疗难治性腹水的一种公认的治疗方式。然而，已知其使用与显著的发病率和死亡率相关。本文报道了一例丹佛分流术患者的病例，尽管分流管通畅，但该患者仍发生了大量心内血栓形成及随后的分流管功能障碍。
